Barely Significant
← all excerpts

Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study.

Front Immunol · 2025 · PMC12679708 · PMID 41357224

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Post hoc pairwise comparisons revealed a highly significant reduction from baseline to day 0 (mean difference: 1,577 [823, 2,331], p < 0.001), while all the other time points were not significantly different from baseline (all p = 1.000).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.